Coya Therapeutics Investor Relations Material
Latest events
Study Update
Coya Therapeutics
Q1 2025
13 May, 2025
Q4 2024
18 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Coya Therapeutics Inc
Access all reports
Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing proprietary therapies that enhance the function of regulatory T cells (Tregs). The company’s therapeutic platforms include Treg-enhancing biologics, Treg-derived exosomes, and autologous Treg cell therapy. These therapies are aimed at treating neurodegenerative, autoimmune, and metabolic diseases. Coya Therapeutics is headquartered in Houston, Texas, and its shares are listed on the NASDAQ.
Key slides for Coya Therapeutics Inc
Study Update
Coya Therapeutics Inc
Investor Presentation
Coya Therapeutics Inc
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
COYA
Country
🇺🇸 United States